Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
达格列净减少凝血酶生成和血小板活化:对降低 2 型糖尿病患者的心血管风险具有重要意义
期刊:Diabetologia
影响因子:8.4
doi:10.1007/s00125-021-05498-0
Christina Kohlmorgen, Stephen Gerfer, Kathrin Feldmann, Sören Twarock, Sonja Hartwig, Stefan Lehr, Meike Klier, Irena Krüger, Carolin Helten, Petra Keul, Sabine Kahl, Amin Polzin, Margitta Elvers, Ulrich Flögel, Malte Kelm, Bodo Levkau, Michael Roden, Jens W Fischer, Maria Grandoch